BioNTech SE
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases.
Lobbying Activity
Meeting with Cecile Billaux (Head of Unit Directorate-General for International Partnerships)
10 Jul 2025 · BioNTech mRNA Vaccine Manufacturing Facility in Rwanda and HDX
Meeting with Ekaterina Zaharieva (Commissioner) and
25 Jun 2025 · - Startup and Scaleup Strategy and Scaleup Europe Fund - Life Sciences Strategy
Meeting with Koen Doens (Director-General Directorate-General for International Partnerships) and
25 Jun 2025 · Global Gateway Agenda on Health
Meeting with Martin Seychell (Deputy Director-General Directorate-General for International Partnerships) and
16 May 2025 · Vaccine development and manufacturing in Africa
Meeting with Martin Seychell (Deputy Director-General Directorate-General for International Partnerships) and
7 May 2025 · Update on Mpox clinical development and R&D and manufacturing landscape for Africa
Meeting with Daphne Von Buxhoeveden (Head of Unit Health Emergency Preparedness and Response Authority), Wolfgang Philipp (Principal Adviser Health Emergency Preparedness and Response Authority)
7 May 2025 · Update on Mpox clinical development and R&D and manufacturing landscape for Africa
Meeting with Laurent Muschel (Acting Director-General Health Emergency Preparedness and Response Authority)
11 Dec 2024 · Pipeline presentation
Meeting with Koen Doens (Director-General Directorate-General for International Partnerships)
22 Feb 2024 · Presentation of their global health activities
Meeting with Stelios Kympouropoulos (Member of the European Parliament) and Moderna, Inc.
17 Jan 2024 · Kangaroo Lunch debate on Platform Technologies and the pharmaceutical legislation review
Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and Moderna, Inc.
16 Jan 2024 · Pharmaceutical legislation
Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and Moderna, Inc.
30 Oct 2023 · Pharmaceutical Package (Directive)
Meeting with Tiemo Wölken (Member of the European Parliament) and
18 Oct 2023 · Pharma Revision - Directive (staff level)
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
13 Oct 2023 · Directive on Medicinal products for human use
Meeting with Véronique Trillet-Lenoir (Member of the European Parliament)
21 Sept 2022 · COVI delegation
Meeting with Ursula von der Leyen (President)
6 Jan 2022 · Meeting with CEO of BioNTech
Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)
6 May 2021 · Site visit and assessment of production capacity and supply chain
Meeting with Ursula von der Leyen (President) and
31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements